These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction. Hiemcke-Jiwa LS, Ten Dam-van Loon NH, Leguit RJ, Nierkens S, Ossewaarde-van Norel J, de Boer JH, Roholl FF, de Weger RA, Huibers MMH, de Groot-Mijnes JDF, Kuiper JJW. JAMA Ophthalmol; 2018 Oct 01; 136(10):1098-1104. PubMed ID: 30027272 [Abstract] [Full Text] [Related]
3. MYD88 L265P MUTATION DETECTION IN THE AQUEOUS HUMOR OF PATIENTS WITH VITREORETINAL LYMPHOMA. Miserocchi E, Ferreri AJM, Giuffrè C, Cangi MG, Francaviglia I, Calimeri T, Ponzoni M, Pecciarini L, Bandello FM, Modorati GM. Retina; 2019 Apr 01; 39(4):679-684. PubMed ID: 30204732 [Abstract] [Full Text] [Related]
4. Serial Detection of MYD88 L265P Mutation in the Aqueous Humor of a Patient with Vitreoretinal Lymphoma for Disease Monitoring. Choi S, Shin S, Lee ST, Lee J, Lee JS, Kim B, Lee CS. Ocul Immunol Inflamm; 2021 Apr 03; 29(3):485-489. PubMed ID: 32965155 [Abstract] [Full Text] [Related]
6. Single B-Cell Genomic Analyses Differentiate Vitreoretinal Lymphoma from Chronic Inflammation. Tan WJ, Wang MM, Castagnoli PR, Tang T, Chan ASY, Lim TS. Ophthalmology; 2021 Jul 03; 128(7):1079-1090. PubMed ID: 33221324 [Abstract] [Full Text] [Related]
7. Vitreoretinal large B- cell lymphoma (VR- LBCL): Clinical and pathological features and treatment outcomes. Fadlelseed H, Rhatigan M, Treacy M, Murphy C, O'Neill J, Kilmartin D, Kennedy S. Pathol Res Pract; 2024 Sep 03; 261():155500. PubMed ID: 39106590 [Abstract] [Full Text] [Related]
8. Anterior segment involvement in vitreoretinal lymphoma: clinical manifestations, molecular findings and in vivo confocal microscopy. Marchese A, Di Biase C, Cicinelli MV, Menean M, Ferrari G, Bandello F, Modorati G, Goldstein DA, Miserocchi E. Br J Ophthalmol; 2024 Jul 23; 108(8):1168-1171. PubMed ID: 37963712 [Abstract] [Full Text] [Related]
9. Clinical spectrum of vitreoretinal lymphoma and its association with MyD88 L265P mutation. Carreno E, Clench T, Steeples LR, Salvatore S, Lee RWJ, Dick AD, Pawade J. Acta Ophthalmol; 2019 Feb 23; 97(1):e138-e139. PubMed ID: 30113125 [No Abstract] [Full Text] [Related]
14. Cell-Free DNA Extraction of Vitreous and Aqueous Humor Specimens for Diagnosis and Monitoring of Vitreoretinal Lymphoma. Brown NA, Rao RC, Betz BL. J Vis Exp; 2024 Jan 12; (203):. PubMed ID: 38284545 [Abstract] [Full Text] [Related]
15. MyD-88 L265P mutations are present in some cases of vitreoretinal lymphoma. Pulido JS, Salomao DR, Frederick LA, Viswanatha DS. Retina; 2015 Apr 12; 35(4):624-7. PubMed ID: 25768255 [Abstract] [Full Text] [Related]
17. PREVALENCE OF MYD88 L265P MUTATION IN HISTOLOGICALLY PROVEN, DIFFUSE LARGE B-CELL VITREORETINAL LYMPHOMA. Raja H, Salomão DR, Viswanatha DS, Pulido JS. Retina; 2016 Mar 12; 36(3):624-8. PubMed ID: 26900675 [Abstract] [Full Text] [Related]
18. Posterior Uveitis in Ocular-Involving Chronic Lymphocytic Leukemia and the Utility of Negative MYD88 L265P Testing in the Diagnosis. Balikov DA, Brown NA, Elner VM, Wubben TJ, Rao RC, Demirci H. Ocul Oncol Pathol; 2024 Jun 12; 10(2):103-113. PubMed ID: 38882022 [Abstract] [Full Text] [Related]